OUR RESEARCH WORK
We believe our research work will help identify new successful treatment options and benefit patients, as well as healthcare providers.
R&D projects are carried out both in Abano Terme’s laboratories and at the Research Unit in Noto (Sicily). The latter’s activities focus on the optimization of biopolymer production (i.e., enzymes, recombinant proteins and polysaccharides), using non-pathogenic host strains of bacteria.
High on the company’s list of priorities is the study of hyaluronic acid, a molecule that at Fidia means tradition, innovation, excellence: approximately 20,000 patients have been involved in over 150 international clinical studies investigating intra-articular hyaluronic acid, whereas nearly 20 million patients have been treated with intra-articular hyaluronic acid-based products so far.
R&D projects are carried out both in Abano Terme’s laboratories and at the Research Unit in Noto (Sicily). The latter’s activities focus on the optimization of biopolymer production (i.e., enzymes, recombinant proteins and polysaccharides), using non-pathogenic host strains of bacteria.
High on the company’s list of priorities is the study of hyaluronic acid, a molecule that at Fidia means tradition, innovation, excellence: approximately 20,000 patients have been involved in over 150 international clinical studies investigating intra-articular hyaluronic acid, whereas nearly 20 million patients have been treated with intra-articular hyaluronic acid-based products so far.